Cargando...
Rosiglitazone and Risk of Cancer: A meta-analysis of randomized clinical trials
OBJECTIVE—Despite experimental data suggesting a protective effect of peroxisome proliferator–activated receptor-γ agonists with respect to malignancies, results of available epidemiological studies on the incidence of cancer in rosiglitazone-treated patients are not univocal. The aim of this meta-a...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
American Diabetes Association
2008
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2453648/ https://ncbi.nlm.nih.gov/pubmed/18375416 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc07-2308 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|